People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trelawney Mining & Exploration Inc. | — | Other | Series A | $10.2M | $64.3M | 2009 |
| XORTX Therapeutics Inc. | — | Pharma | Seed | $2.3M | $7.2M | 2024 |
James Fairbairn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Fairbairn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Irwin | 1 | 10 |
| Anthony Makuch | 1 | 7 |
| Greg Gibson | 1 | 6 |
| William Farley | 1 | 4 |
| Andres Tinajero | 1 | 4 |
| John Meekison | 1 | 3 |
| Anthony J. Giovinazzo | 1 | 3 |
| Alan Moore | 1 | 3 |
| Patrick Mohan | 1 | 2 |
| Charlotte May | 1 | 2 |
| Geroge Cole | 1 | 1 |
| Charlotte Mays | 1 | 1 |
| George Cole | 1 | 1 |
| Allen Davidoff | 1 | 1 |
| Paul J. Van Damme | 1 | 1 |
| Abigail J. Jenkins | 1 | 1 |
| Stephen Haworth | 1 | 1 |
| Stacy Evans | 1 | 1 |
| Raymond J. Pratt | 1 | 1 |
| Patrick J. Treanor | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.